Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
3 Dividend Stocks to Sell Before They Get Sued by Customers
06:35am, Tuesday, 18'th Apr 2023
Companies in getting sued by customers are the dividend stocks to avoid. Shareholders who sue the company are less serious.
Johnson & Johnson beats Q1 consensus estimates and raises guidance
06:33am, Tuesday, 18'th Apr 2023
Johnson & Johnson's stock JNJ, -0.10% rose 1.4% in premarket trade Tuesday, after the consumer health and pharma company beat consensus estimates for its first quarter and raised its full-year guidanc
J&J talc unit again seeks to halt 38,000 cancer lawsuits
06:08am, Tuesday, 18'th Apr 2023
A Johnson & Johnson subsidiary is again asking a U.S. judge to pause tens of thousands of lawsuits alleging that the company's baby powder and other talc products cause cancer, as it takes another sho
The Fed Thinks a Recession Is More Likely: Here Are 3 Great Stocks to Buy Now
05:52am, Tuesday, 18'th Apr 2023
Dollar General is arguably the ultimate recession-proof stock. Johnson & Johnson is a favorite safe-haven stock for investors during economic downturns.
How To Allocate $10,000 Among My Top 20 Dividend Stocks Of April 2023
02:00pm, Monday, 17'th Apr 2023
In this article, I will show you how you could allocate $10,000 among my top 20 dividend growth and high dividend yield companies for the month of April. Due to the allocation I have chosen, that I'll
Is Johnson & Johnson a Buy After Its Proposed $8.9 Billion Talc Settlement?
08:36am, Monday, 17'th Apr 2023
The $8.9 billion talcum-powder settlement agreement isn't final, but it's progress. Johnson & Johnson can easily afford its litigation costs.
2 Best Biotech Stocks to Buy for the Long Haul
05:10am, Monday, 17'th Apr 2023
Johnson & Johnson and Novartis both have robust product portfolios and pipelines. Each company pays a safe and market-topping dividend to shareholders.
2 of the Lowest-Risk Dividend Stocks in the World
10:31am, Sunday, 16'th Apr 2023
Johnson & Johnson and Microsoft have AAA-rated credit, tied for best in the world. The companies also produce prodigious cash flows that easily cover their payouts.
Apple Among 14 Companies To Announce Dividend Growth In Late April
08:20am, Sunday, 16'th Apr 2023
Procter & Gamble extended its dividend growth streak to 67 years in the first two weeks of April with a 3% increase. Most of the increases I expected in the first half of April will actually occur in
Why Johnson & Johnson Is Such an Impressive Dividend Stock
09:50am, Saturday, 15'th Apr 2023
Having a dividend growth streak isn't impressive if a company only makes modest increases to keep the streak going. Johnson & Johnson has been generous when it comes to dividend rate hikes, with its l
Johnson & Johnson Stock: Bear vs. Bull
07:20am, Saturday, 15'th Apr 2023
Johnson & Johnson will soon undergo a major transformation via a spinoff. Management hasn't fully elaborated on how the spinoff will help shareholders.
3 Dividend Stocks to Buy and Hold for the Next Decade
06:14am, Saturday, 15'th Apr 2023
AbbVie faces near-term challenges but has solid long-term prospects plus an especially attractive dividend. Gilead Sciences' strong free cash flow should enable the company to continue raising its div
Dividend Income Summary: Lanny's March 2023 Summary
04:06am, Saturday, 15'th Apr 2023
In March, we (my wife and I) received a dividend income total of $5,707.34. Target, Lockheed Martin and T. Rowe Price are 3 dividend growth stocks that sent massive dividend payments our way, all over
J&J (JNJ) to Initiate Q1 Earnings Season for Pharma Sector
10:39am, Friday, 14'th Apr 2023
Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex and Stelara. In the MedTech segment, continued recovery in worldwide procedure volume should drive sales.
Why Johnson & Johnson Paying $8.9 Billion to Settle Its Talc Lawsuits Would Be Good News
08:45am, Friday, 14'th Apr 2023
Johnson & Johnson has plenty of incentive to settle its talc lawsuits. A drawn-out court process would be costly and create uncertainty for investors.
